Histopathological activity in paucibacillary leprosy patients after ROM therapy

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 67, Issue 4, 1999, Pages 409-413

  Ebenezer, Gigi J ^a   Job, Charles K ^b  

^a Dept Histopathology Exp Pathol ^*  (India)

^b Schieffelin Leprosy Res/Train C   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MINOCYCLINE; OFLOXACIN; RIFAMPICIN;

ADOLESCENT; ADULT; ARTICLE; BACTERIUM ISOLATION; BORDERLINE LEPROSY; CHILD; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GRANULOMA; HISTOPATHOLOGY; HUMAN; MALE; MYCOBACTERIUM LEPRAE; SKIN BIOPSY; TUBERCULOID LEPROSY;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GRANULOMA; HUMANS; LEPROSY, LEPROMATOUS; MALE; MINOCYCLINE; OFLOXACIN; RIFAMPIN; SKIN;

EID: 0033376708     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. FAJARDO, T. T. JR., VILLAHERMOS, L. G., DELA CRUZ, E. C., ABALOS, R. M., FRANZBLAU, S. G. and WALSH, G. P. Minocycline in lepromatous leprosy. Int. J. Lepr. 63 (1995) 8-17.
2. GELBER, R. H. Activity of minocycline in Mycobacterium leprae-infected mice. J. Infect. Dis. 156 (1987) 236-239.
3. GELBER, R. H., MURRAY, L. P., SIU, P., PSANG, M. and REA, T. H. Efficacy of minocycline in single dose and 100 mg twice daily for lepromatous leprosy. Int. J Lepr. 62 (1994) 568-573.
4. GUPTE, M. D. Presidential address. XIX Biennial Conference of Indian Association of Leprologists: 15-17 December 1995, Pune. Indian J. Lepr. 68 (1996) 211-213.
5. JI, B., JAMET, P., PERANI, E. G., SOW, S., LIENHARDT, C., PETINON, C. and GROSSET, J. H. Bactericidal activity of single dose of clarithromycin plus minocycline with or without ofloxacin, against Mycobacterium leprae in patients. Antimicrobiol. Agents Chemother. 40 (1996) 2137-2141.
6. JI, B., PERANI, E. G., PETINON, C. and GROSSET, J. H. Bactericidal activities of combinations of new drugs against M. leprae in nude mice. Antimicrobiol. Agents Chemother. 40 (1996) 393-399.
7. JI, B., PERANI, E. G., PETINON, C. and GROSSET, J. H. Bacterial activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice. Int. J. Lepr. 60 (1992) 556-561.
8. JOB, C. K. and CHACKO, C. J. G. A modification of Fite's stain for demonstration of M. leprae in tissue sections. Int. J. Lepr. 58 (1986) 70-80.
9. JOB, C. K., JEYAKUMAR, J. and ASCHHOFF, M. Delayed resolution versus treatment failure in paucibacillary leprosy patients under six months fixed duration multidrug therapy. Indian J. Lepr. 69 (1997) 131-142.
10. LEVY, L., SHEPARD, C. C. and FASAL, P. The bactericidal effect of rifampin on M. leprae in man: a) single doses of 600, 900 and 1200 mg; and b) daily doses of 300 mg. Int. J. Lepr. 44 (1976) 183-187.
11. PEAT, M., BROLIN, L., GANAPATI, R., MCDOUGALL A. C., REVANKAR, C. R. and WATSON, J. W. An evaluation of the contribution of the Swedish International Developmental Authority (SIDA) to leprosy control in India based on the implementation of multidrug therapy (MDT) 1981-1993. Indian J. Lepr. 67 (1995) 447-465.
12. RIDLEY, D. S. and JOPLING, W. H. Classification of leprosy according to immunity; a five-group system. Int. J. Lepr. 34 (1966) 255-273.
13. SINGLE-LESION MULTICENTRIC TRIAL GROUP. Efficacy of single dose multidrug therapy for the treatment of single lesion paucibacillary leprosy. Indian J. Lepr. 69 (1997) 121-129.
14. WHO EXPERT COMMITTEE ON LEPROSY. Seventh Report. Geneva: World Health Organization, 1998, pp. 18-19. Tech. Rep. Ser. 874.
15. WORLD HEALTH ORGANIZATION. A guide to eliminating leprosy as a public health problem. Geneva: World Health Organization, 1995, p. 21.